FIELD: medicine.
SUBSTANCE: the invention relates to medicine, in particular, to haematology, and can be used for stimulation of myelogenesis. Pegylated hyaluronidase is administered with the dosage of 50 action units/kg 1 time a day for two days, additionally a medication containing D-glucuronic acid is intravenously administered once with the dosage of 2 mg/kg.
EFFECT: accelerated regenerative processes of haemopoietic tissues with additional administration of low doses of D-glucuronic acid, caused by its regulatory influence on hyaluronic acid metabolism of blood-forming precursors.
3 tbl, 1 ex, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF MYELOPOIESIS STIMULATION | 2007 |
|
RU2336899C1 |
HEMOSTIMULANT AND EXCITANT AND METHOD FOR HEMOPOIESIS STIMULATION | 2009 |
|
RU2414926C1 |
METHOD OF MYELOPOIESIS STIMULATION | 2008 |
|
RU2366452C1 |
HAEMOSTIMULATING AGENT | 2013 |
|
RU2535021C1 |
HEMOSTIMULATING MEDICATION | 2012 |
|
RU2505308C1 |
METHOD FOR PREPARING CELL TRANSPLANTATION MATERIAL IN MYELOSUPPRESSION | 2008 |
|
RU2392947C1 |
METHOD OF DETERMINING EFFICACY OF HAEMOSTIMULATORS IN CYTOSTATIC MYELOSUPPRESSION | 2009 |
|
RU2421720C2 |
HEMOSTIMULATING AGENT | 2013 |
|
RU2514648C1 |
METHOD OF STIMULATION IN VITRO PLURIPOTENT HEMOPOETIC STEM CELLS | 2010 |
|
RU2439147C1 |
MEDICATION POSSESSING HAEMOSTIMULATING, ANTIMUTAGENIC, ANTITUMOUR, CEREBROPROTECTIVE, ANTIHYPOXIC, NOOTROPIC, ANXIOLYTIC AND ANTINEUROTIC ACTION | 2010 |
|
RU2438691C1 |
Authors
Dates
2012-02-20—Published
2010-10-11—Filed